Transforming Pharmacy Care

James Hopper is a healthcare executive with 25+ years of experience driving growth across startups and global matrix organizations. He has led global business development and M&A initiatives in oncology and precision medicine at ThermoFisher Scientific. James played a pivotal role in the development and $40M acquisition of the Novii fetal monitor by GE Healthcare. His expertise spans molecular diagnostics, pharmacogenomics, and health economics, with a strategic focus on innovation, commercialization, and transaction execution.

Scott retired as Senior Vice President and Chief Information Officer of Blue Cross Blue Shield of Alabama, where he served for over a decade leading payer IT strategy and data integration. Previously, he held senior technology and operations roles at Synovus, giving him deep expertise in enterprise infrastructure and claims data management. His career focus has been on aligning IT systems to improve quality, efficiency, and compliance. At SmartDoseRx, Scott helps position the platform to align with payer adoption and STAR metrics.

Grey has over 25 years of leadership in business development, finance, and economic development. His career includes senior roles in technology, banking, and telecommunications, where he built strategies that balanced growth with operational rigor. He earned a BA from Hendrix College and an MBA from Vanderbilt University. At SmartDoseRx, Grey provides financial strategy and oversight, ensuring strong capital discipline, sustainable growth, and the ability to scale predictive prescribing solutions into health plans, health systems, and value-based care models.

Adam is a healthcare executive with deep expertise in the independent lab industry. As Founder and CEO of Lab Works, he built and scaled the laboratory into a high-growth business that was acquired by LabCorp in 2024. Today, he advises diagnostic startups, specializing in compliance, billing and coding, test menu development, commercialization strategy, and growth planning. His experience in lab operations, marketing, and organizational leadership provides SmartDoseRx with critical and practical insight into scaling diagnostics, optimizing portfolios, and driving sustainable success in precision prescribing.

Scott retired as Senior Vice President and Chief Information Officer of Blue Cross Blue Shield of Alabama, where he served for over a decade leading payer IT strategy and data integration. Previously, he held senior technology and operations roles at Synovus, giving him deep expertise in enterprise infrastructure and claims data management. His career focus has been on aligning IT systems to improve quality, efficiency, and compliance. At SmartDoseRx, Scott helps position the platform to align with payer adoption and STAR metrics.

David brings more than 30 years of experience scaling healthcare companies and driving high-value partnerships. As a VP at Optum, he managed major health system contracts, and as founder of MedSource, he guided over 40 investments generating $90M in profits. His background spans pharmacy, health systems, and healthcare technology. With expertise in payer strategy, venture capital, and commercialization, David ensures SmartDoseRx accelerates adoption across payers and providers, delivering financial returns and clinical impact through precision-guided medication management.

Dr. Shawn Dalton, PharmD, BCPS, BCACP, BCPP, is a nationally recognized leader in pharmacogenomics, personalized prescribing, and program development. He directed the U.S. Department of Veterans Affairs’ Telepharmacogenomics (NTPGx) program, one of the largest efforts to integrate genetic testing into routine care, improving prescribing decisions for veterans nationwide. Beyond precision medicine, he has built innovative programs in mental health, pain, and addiction care. With more than a decade of leadership, Dr. Dalton brings clinical depth and strategic vision to SmartDoseRx. 

Jeremy earned his PhD in Genetics and Complex Diseases from Harvard University and has held leadership roles in multiple life science startups. He currently serves as Senior Director of Genetics and Genomics at MUSC, where he leads innovation in clinical genomics and precision medicine. His expertise spans laboratory-developed test validation, translational research, and scientific strategy. At SmartDoseRx, Jeremy strengthens the scientific foundation of the platform, ensuring rigorous development and clinical alignment to advance precision prescribing at population scale.